The Effect of Huperzine A Injection on Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage: a Pilot Study
Clinical trial NCT05560373 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05560373
- Sponsor
- Wanbangde Pharmaceutical Group Co., LTD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-31
- Primary completion
- 2029-12-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.